Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles

The more stunning AI agents become, the more valuable storage gets! SK Hynix's NAND business landscape is brewing a hundred-billion-dollar U.S. stock IPO.
HK Bull/Bear Outstanding Qty Ratio(57:43) | September 26

Oracle Corporation (ORCL.US) "Force Majeure" Notice Shakes the AI Bond Market! Morgan Stanley: Data Center Financing Contracts Face Re-examination
The more stunning AI agents become, the more valuable storage gets! SK Hynix's NAND business landscape is brewing a hundred-billion-dollar U.S. stock IPO.

HK Bull/Bear Outstanding Qty Ratio(57:43) | September 26
Oracle Corporation (ORCL.US) "Force Majeure" Notice Shakes the AI Bond Market! Morgan Stanley: Data Center Financing Contracts Face Re-examination






